No requirement for TRAIL in intrathymic negative selection

International Immunology

Volumn 20, Issue 2, 2008, Pages 267-276

  Cretney, Erika ^a   Uldrich, Adam P ^a   McNab, Finlay W ^b   Godfrey, Dale I ^b   Smyth, Mark J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Apoptosis; Autoimmune disease; Negative selection; Thymus; TRAIL

Indexed keywords

CD3 ANTIGEN; DEATH RECEPTOR 5; FAS LIGAND; PEPTIDE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; C57BL 6 MOUSE; CONTROLLED STUDY; DENDRITIC CELL; EMBRYO; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL SELECTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYMOCYTE; TRANSGENICS;

ANIMALS; ANTIGENS, CD3; APOPTOSIS; AUTOIMMUNE DISEASES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SELECTION (GENETICS); THYMUS GLAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 39049123825     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm144     Document Type: Article

References (66)

1. Starr, T. K., Jameson, S. C. and Hogquist, K. A. 2003. Positive and negative selection of T cells. Annu. Rev. Immunol. 21:139.
2. Goldrath, A. W. and Bevan, M. J. 1999. Selecting and maintaining a diverse T-cell repertoire. Nature 402:255.
3. Palmer, E. 2003. Negative selection - clearing out the bad apples from the T-cell repertoire. Nat. Rev. Immunol. 3:383.
4. Anderson, M. S., Venanzi, E. S., Klein, L. et al. 2002. Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395.
5. Bouillet, P, Metcalf, D., Huang, D. C. et al. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735.
6. Bouillet, P., Purton, J. F., Godfrey, D. I. et al. 2002. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415:922.
7. Liston, A., Lesage, S., Wilson, J., Peltonen, L. and Goodnow, C. C. 2003. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4:350.
8. Stockinger, B. 1999. T lymphocyte tolerance: From thymic deletion to peripheral control mechanisms. Adv. Immunol. 71:229.
9. Kishimoto, H. and Sprent, J. 1997. Negative selection in the thymus includes semimature T cells. J. Exp. Med. 185:263.
10. Calnan, B. J., Szychowski, S., Chan, F. K., Cado, D. and Winoto, A. 1995. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 3:273.
11. Lee, S. L., Wesselschmidt, R. L., Linette, G. P., Kanagawa, O., Russell, J. H. and Milbrandt, J. 1995. Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 269-532.
12. Cheng, L. E., Chan, F. K., Cado, D. and Winoto, A. 1997. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J. 16:1865.
13. Rathmell, J. C., Lindsten, T., Zong, W. X., Cinalli, R. M. and Thompson, C. B. 2002. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat. Immunol. 3:932.
14. Wang, E. C., Thern, A., Denzel,. A., Kitson, J., Farrow, S. N. and Owen, M. J. 2001. DR3 regulates negative selection during thymocyte development. Mol. Cell. Biol. 21:3451.
15. Wang, J., Chun, H. J., Wong, W., Spencer, D. M. and Lenardo, M. J. 2001..Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl Acad. Sci. USA 98:13884.
16. Diehl, G. E., Yue, H. H., Hsieh, K. et al. 2004. TRAIL-R as a negative regulator of innate immune cell responses. Immunity 21:877.
17. Page, D. M., Roberts, E. M., Peschon, J. J. and Hedrick, S. M. 1998. TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J. Immunol. 160:120.
18. Grech, A. P., Riminton, D. S., Gabor, M. J., Hardy, C. L., Sedgwick, J. D. and Godfrey, D. I. 2000. Increased thymic B cells but maintenance of thymic structure, T cell differentiation and negative selection in lymphotoxin-alpha and TNF gene-targeted mice. Dev. Immunol. 8:61.
19. Amakawa, R., Hakem, A., Kundig, T. M. et al. 1996. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551.
20. Chiarle, R., Podda, A., Prolla, G., Podack, E. R., Thorbecke, G. J. and Inghirami, G. 1999. CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway, J. Immunol. 163:194.
21. DeYoung, A. L., Duramad, O. and Winoto, A. 2000. The TNF receptor family member CD30 is not essential for negative selection. J. Immunol. 165:6170.
22. Kishimoto, H. and Sprent, J. 1999. Several different cell surface molecules control negative selection of medullary thymocytes. J. Exp. Med. 190:65.
23. Kishimoto, H., Surh, C. D. and Sprent, J. 1998. A role for Fas in negative selection of thymocytes in vivo. J. Exp. Med. 187:1427.
24. Lamhamedi-Cherradi, S. E., Zheng, S. J., Maguschak, K. A., Peschon, J. and Chen, Y. H. 2003. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat. Immunol. 4:255.
25. Page, D. M. 1999. Cutting edge: Thymic selection and autoreactivity are regulated by multiple coreceptors involved in T cell activation. J. Immunol. 163:3577.
26. Simon, A. K., Williams, O., Mongkolsapaya, J. et al. 2001. Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes. Proc. Natl Acad. Sci. USA 98:5158.
27. Cretney, E., Uldrich, A. P., Berzils, S. P., Strasser, A., Godfrey, D. I. and Smyth, M. J. 2003. Normal thymocyte negative selection in TRAIL-deficient mice. J. Exp. Med. 198:491.
28. Corazza, N., Brumatti, G., Jakob, S., Villunger, A. and Brunner, T. 2004. TRAIL and thymocytey-apoptosis: Not so deadly? Cell Death Differ. 11 (Suppl. 2): S213.
29. Wang, J. and Fu, Y. X. 2003. LIGHT (a cellular-ligand for herpes-virus entry mediator and lymphotoxin receptor)-mediated thymocyte deletion is dependent on the interaction between TCR and MHC/self-peptide. J. Immunol. 170:3986.
30. Sidman, C. L., Marshall, J. D. and Von Boehmer, H. 1992. Transgenic T cell receptor interactions in the lymphobroliferative and autoimmune syndromes of lpr and gld mutant mice. Eur. J. Immunol. 22:499.
31. Villunger, A. Marsden, V. S., Zhan, Y. et al. 2004. Negative selection of seminature, CD4(+)8(k)HSA+ thymocytes requires the BH3-only protein. Bim but is independent of death receptor signaling. Proc. Natl Acad. Sci. USA 101:7052.
32. Newton, K., Harris, A.W., Bath, M. L., Smith, K. G. and Strasser, A. 1998. A dominant interfering mutant of FADD/MORT1. enhances deletion of autoreactive thymocytes and inhibits-proliferation of mature T lymphocytes. EMBO J. 17:706.
33. Smith, K. G., Strasser, A. and Vaux, D.L. 1996. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1) transduced apoptosis, but does not cause lymphadenopathy of autoimmune disease. EMBO J. 15:5167.
34. Green, D. R. 2003. The suicide in the thymus, a twisted, trail. Nat. Immunol. 4:207.
35. Cretney, E., Takeda, K., Yagita, H., Glaccum M., Peschen, J. J. and Smyth, M. J. 2002. Increased susceptibility to tumor initiation and metastasis in TNF-refated apoptosis-inducing ligand-deficient mice. J. Immunol. 168:1356.
36. Cohen, P. L. and Eisenberg, R. A. 1991. Lot and gld: Single gene models of sytemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
37. Davidson, W. F., Dumont, F. J., Bedigian, H. G., Fowlkes, B. J. and Morse, H. C. III 1986. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/ gld mice. J. Immunol. 136:4075.
38. Kayagaki, N., Yamaguchi, N., Nakayama, M. et al. 1999. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol. 163:1906.
39. Korner, H., Cretney, E., Wilhelm, P. et al. 2000. Tumor necrosis factor sustains the generalized lymphaproliferative disorder (gld) phenotype. J. Exp. Med. 191:89.
40. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J. and Carbone, F. B. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
41. Finnberg, N., Gruber, J. J., Fei, P. et al. 2005. DR5 knockout mice are compromised in radiation-induced apoptosis. Mol. Cell. Biol. 25:2000.
42. Gallegos, A. M. and Bevan, M. J. 2006. Central tolerance: Good but imperfect. Immunol. Rev. 209:290.
43. Ebling, F. and Hahn, B. H. 1980. Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates. Arthritis Rheum. 23:392.
44. Camacho, I. A., Nagarkatti, M. and Nagarkatti, P. S. 2004. Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci. 78:96.
45. Newton, K., Harris, A. W. and Strasser, A. 2000. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J. 19:931.
46. Kiss, I., Oskolas, H., Toth, R. et al. 2006. Adenosine A2A receptor-mediated cell death of mouse thymocytes involves adenylate cyclase and Bim and is negatively regulated by Nur77. Eur. J. Immunol. 36:1559.
47. Takahama, Y. 2006. Journey through the thymus: Stromal guides for T-cell development and selection. Nat. Rev. Immunol. 6:127.
48. Nagamine, K., Peterson, P., Scott, H. S. et al. 1997. Positional cloning of the APECED gene. Nat. Genet. 17:393.
49. Vidal, S., Kono, D. H. and Theofilopoulos, A. N. 1998. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J. Clin. Investig. 101:696.
50. Izui, S., Kelley, V. E., Masuda, K., Yoshida, H., Roths, J. B. and Murphy, E. D. 1984, Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133:227.
51. Hughes, P., Bouillet, P. and Strasser, A. 2006, Role of Bim and other Bcl-2 family members in autoimmune and degenerative diseases. Curr. Dir. Autoimmun. 9:74.
52. Cretney, E., McQualter, J. L., Kayagaki, N. et al. 2005. TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. Immunol. Cell Biol. 83:511.
53. Lamhamedi-Cherradi, S. E., Zheng, S., Tisch, R. M. and Chen, Y. H, 2003. Critical rolos of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes. Diabetes 52:2274.
54. Hilliard, B., Wilmen, A., Seidel, C., Liu, T. S., Goke, R. and Chen, Y. 2001. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J. Immunol. 166:1314.
55. Sorlg, K,, Chen, Y., Goke, R. et al. 2000. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J. Exp. Med. 191:1095.
56. Zhang, X. R., Zhang, L. Y., Devadas, S., Li, L., Keegan, A. D. and Shi, Y. F. 2005. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells role of apoptosis in T helper subset differentiation. Cell Death Differ. 10:203.
57. Martinez-Lorenzo, M. J., Alava, M. A., Gamen, S. et al. 1998. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J. Immunol. 28:2714.
58. Janssen, E. M., Droin, N. M., Lemmens, E. E. et al. 2005. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434:88.
59. Fanger, N. A., Maliszewski, C. R.., Schooley, K. and Griffith, T S. 1999. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med. 190:F155.
60. Lee, I. F., Qin, H., Trudeau, J., Dutz, J. and Tan, R. 2004. Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J. Immunol. 172:937.
61. Shi, F. D., Wang, H. B., Li, H. et al. 2000. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat. Immunol. 1:245.
62. Zheng, C. L., Hossain, M. A., Kukita, A., Ohki, K., Satoh, T. and Kohashi, O. 2002. Complete Freund's adjuvant suppresses the development and progression of pristane-induced arthritis in rats. Clin. Immunol. 103:204.
63. Zheng, C. L., Ohki, K., Hossain, A., Kukita, A., Satoh, T. and Kohashi, O. 2003. Complete Freund's adjuvant promotes the increases of IFN-gamma and nitric oxide in suppressing chronic arthritis induced by pristane. Inflammation 27:247.
64. Takeda, K., Hayakawa, Y., Smyth, M. J. et al. 2001. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 7:94.
65. Martin, S. and Bevan, M. J. 1997: Antigen-specific and non-specific deletion of immature cortical thymocytes caused by antigen, injection. Eur J. Immunol. 27:2726.
66. Brewer, J. A., Kanagawa, O., Sleckman, B. P. and Muglia, L. J. 2002. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J. Immunol. 169:1837.